- IBDEI0SM ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,12880,0)
- ;;=H34.8321^^51^623^8
- ;;^UTILITY(U,$J,358.3,12880,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12880,1,3,0)
- ;;=3^BRVO,OS w/ Retinal Neovascularization
- ;;^UTILITY(U,$J,358.3,12880,1,4,0)
- ;;=4^H34.8321
- ;;^UTILITY(U,$J,358.3,12880,2)
- ;;=^5138492
- ;;^UTILITY(U,$J,358.3,12881,0)
- ;;=H34.8322^^51^623^9
- ;;^UTILITY(U,$J,358.3,12881,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12881,1,3,0)
- ;;=3^BRVO,OS,Stable
- ;;^UTILITY(U,$J,358.3,12881,1,4,0)
- ;;=4^H34.8322
- ;;^UTILITY(U,$J,358.3,12881,2)
- ;;=^5138493
- ;;^UTILITY(U,$J,358.3,12882,0)
- ;;=H34.8110^^51^623^10
- ;;^UTILITY(U,$J,358.3,12882,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12882,1,3,0)
- ;;=3^CRVO,OD w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,12882,1,4,0)
- ;;=4^H34.8110
- ;;^UTILITY(U,$J,358.3,12882,2)
- ;;=^5138476
- ;;^UTILITY(U,$J,358.3,12883,0)
- ;;=H34.8111^^51^623^11
- ;;^UTILITY(U,$J,358.3,12883,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12883,1,3,0)
- ;;=3^CRVO,OD w/ Retinal Neovascularization
- ;;^UTILITY(U,$J,358.3,12883,1,4,0)
- ;;=4^H34.8111
- ;;^UTILITY(U,$J,358.3,12883,2)
- ;;=^5138477
- ;;^UTILITY(U,$J,358.3,12884,0)
- ;;=H34.8112^^51^623^12
- ;;^UTILITY(U,$J,358.3,12884,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12884,1,3,0)
- ;;=3^CRVO,OD,Stable
- ;;^UTILITY(U,$J,358.3,12884,1,4,0)
- ;;=4^H34.8112
- ;;^UTILITY(U,$J,358.3,12884,2)
- ;;=^5138478
- ;;^UTILITY(U,$J,358.3,12885,0)
- ;;=H34.8120^^51^623^13
- ;;^UTILITY(U,$J,358.3,12885,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12885,1,3,0)
- ;;=3^CRVO,OS w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,12885,1,4,0)
- ;;=4^H34.8120
- ;;^UTILITY(U,$J,358.3,12885,2)
- ;;=^5138479
- ;;^UTILITY(U,$J,358.3,12886,0)
- ;;=H34.8121^^51^623^14
- ;;^UTILITY(U,$J,358.3,12886,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12886,1,3,0)
- ;;=3^CRVO,OS w/ Retinal Neovascularization
- ;;^UTILITY(U,$J,358.3,12886,1,4,0)
- ;;=4^H34.8121
- ;;^UTILITY(U,$J,358.3,12886,2)
- ;;=^5138480
- ;;^UTILITY(U,$J,358.3,12887,0)
- ;;=H34.8122^^51^623^15
- ;;^UTILITY(U,$J,358.3,12887,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12887,1,3,0)
- ;;=3^CRVO,OS,Stable
- ;;^UTILITY(U,$J,358.3,12887,1,4,0)
- ;;=4^H34.8122
- ;;^UTILITY(U,$J,358.3,12887,2)
- ;;=^5138481
- ;;^UTILITY(U,$J,358.3,12888,0)
- ;;=H35.013^^51^623^40
- ;;^UTILITY(U,$J,358.3,12888,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12888,1,3,0)
- ;;=3^Changes in Retinal Vascular Appearance,OU
- ;;^UTILITY(U,$J,358.3,12888,1,4,0)
- ;;=4^H35.013
- ;;^UTILITY(U,$J,358.3,12888,2)
- ;;=^5005584
- ;;^UTILITY(U,$J,358.3,12889,0)
- ;;=H35.011^^51^623^38
- ;;^UTILITY(U,$J,358.3,12889,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12889,1,3,0)
- ;;=3^Changes in Retinal Vascular Appearance,OD
- ;;^UTILITY(U,$J,358.3,12889,1,4,0)
- ;;=4^H35.011
- ;;^UTILITY(U,$J,358.3,12889,2)
- ;;=^5005582
- ;;^UTILITY(U,$J,358.3,12890,0)
- ;;=H35.012^^51^623^39
- ;;^UTILITY(U,$J,358.3,12890,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12890,1,3,0)
- ;;=3^Changes in Retinal Vascular Appearance,OS
- ;;^UTILITY(U,$J,358.3,12890,1,4,0)
- ;;=4^H35.012
- ;;^UTILITY(U,$J,358.3,12890,2)
- ;;=^5005583
- ;;^UTILITY(U,$J,358.3,12891,0)
- ;;=H35.023^^51^623^43
- ;;^UTILITY(U,$J,358.3,12891,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12891,1,3,0)
- ;;=3^Exudative Retinopathy,OU
- ;;^UTILITY(U,$J,358.3,12891,1,4,0)
- ;;=4^H35.023
- ;;^UTILITY(U,$J,358.3,12891,2)
- ;;=^5005588
- ;;^UTILITY(U,$J,358.3,12892,0)
- ;;=H35.021^^51^623^41
- ;;^UTILITY(U,$J,358.3,12892,1,0)
- ;;=^358.31IA^4^2
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0SM 3789 printed Feb 18, 2025@23:21:20 Page 2
- IBDEI0SM ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,12880,0)
- +2 ;;=H34.8321^^51^623^8
- +3 ;;^UTILITY(U,$J,358.3,12880,1,0)
- +4 ;;=^358.31IA^4^2
- +5 ;;^UTILITY(U,$J,358.3,12880,1,3,0)
- +6 ;;=3^BRVO,OS w/ Retinal Neovascularization
- +7 ;;^UTILITY(U,$J,358.3,12880,1,4,0)
- +8 ;;=4^H34.8321
- +9 ;;^UTILITY(U,$J,358.3,12880,2)
- +10 ;;=^5138492
- +11 ;;^UTILITY(U,$J,358.3,12881,0)
- +12 ;;=H34.8322^^51^623^9
- +13 ;;^UTILITY(U,$J,358.3,12881,1,0)
- +14 ;;=^358.31IA^4^2
- +15 ;;^UTILITY(U,$J,358.3,12881,1,3,0)
- +16 ;;=3^BRVO,OS,Stable
- +17 ;;^UTILITY(U,$J,358.3,12881,1,4,0)
- +18 ;;=4^H34.8322
- +19 ;;^UTILITY(U,$J,358.3,12881,2)
- +20 ;;=^5138493
- +21 ;;^UTILITY(U,$J,358.3,12882,0)
- +22 ;;=H34.8110^^51^623^10
- +23 ;;^UTILITY(U,$J,358.3,12882,1,0)
- +24 ;;=^358.31IA^4^2
- +25 ;;^UTILITY(U,$J,358.3,12882,1,3,0)
- +26 ;;=3^CRVO,OD w/ Macular Edema
- +27 ;;^UTILITY(U,$J,358.3,12882,1,4,0)
- +28 ;;=4^H34.8110
- +29 ;;^UTILITY(U,$J,358.3,12882,2)
- +30 ;;=^5138476
- +31 ;;^UTILITY(U,$J,358.3,12883,0)
- +32 ;;=H34.8111^^51^623^11
- +33 ;;^UTILITY(U,$J,358.3,12883,1,0)
- +34 ;;=^358.31IA^4^2
- +35 ;;^UTILITY(U,$J,358.3,12883,1,3,0)
- +36 ;;=3^CRVO,OD w/ Retinal Neovascularization
- +37 ;;^UTILITY(U,$J,358.3,12883,1,4,0)
- +38 ;;=4^H34.8111
- +39 ;;^UTILITY(U,$J,358.3,12883,2)
- +40 ;;=^5138477
- +41 ;;^UTILITY(U,$J,358.3,12884,0)
- +42 ;;=H34.8112^^51^623^12
- +43 ;;^UTILITY(U,$J,358.3,12884,1,0)
- +44 ;;=^358.31IA^4^2
- +45 ;;^UTILITY(U,$J,358.3,12884,1,3,0)
- +46 ;;=3^CRVO,OD,Stable
- +47 ;;^UTILITY(U,$J,358.3,12884,1,4,0)
- +48 ;;=4^H34.8112
- +49 ;;^UTILITY(U,$J,358.3,12884,2)
- +50 ;;=^5138478
- +51 ;;^UTILITY(U,$J,358.3,12885,0)
- +52 ;;=H34.8120^^51^623^13
- +53 ;;^UTILITY(U,$J,358.3,12885,1,0)
- +54 ;;=^358.31IA^4^2
- +55 ;;^UTILITY(U,$J,358.3,12885,1,3,0)
- +56 ;;=3^CRVO,OS w/ Macular Edema
- +57 ;;^UTILITY(U,$J,358.3,12885,1,4,0)
- +58 ;;=4^H34.8120
- +59 ;;^UTILITY(U,$J,358.3,12885,2)
- +60 ;;=^5138479
- +61 ;;^UTILITY(U,$J,358.3,12886,0)
- +62 ;;=H34.8121^^51^623^14
- +63 ;;^UTILITY(U,$J,358.3,12886,1,0)
- +64 ;;=^358.31IA^4^2
- +65 ;;^UTILITY(U,$J,358.3,12886,1,3,0)
- +66 ;;=3^CRVO,OS w/ Retinal Neovascularization
- +67 ;;^UTILITY(U,$J,358.3,12886,1,4,0)
- +68 ;;=4^H34.8121
- +69 ;;^UTILITY(U,$J,358.3,12886,2)
- +70 ;;=^5138480
- +71 ;;^UTILITY(U,$J,358.3,12887,0)
- +72 ;;=H34.8122^^51^623^15
- +73 ;;^UTILITY(U,$J,358.3,12887,1,0)
- +74 ;;=^358.31IA^4^2
- +75 ;;^UTILITY(U,$J,358.3,12887,1,3,0)
- +76 ;;=3^CRVO,OS,Stable
- +77 ;;^UTILITY(U,$J,358.3,12887,1,4,0)
- +78 ;;=4^H34.8122
- +79 ;;^UTILITY(U,$J,358.3,12887,2)
- +80 ;;=^5138481
- +81 ;;^UTILITY(U,$J,358.3,12888,0)
- +82 ;;=H35.013^^51^623^40
- +83 ;;^UTILITY(U,$J,358.3,12888,1,0)
- +84 ;;=^358.31IA^4^2
- +85 ;;^UTILITY(U,$J,358.3,12888,1,3,0)
- +86 ;;=3^Changes in Retinal Vascular Appearance,OU
- +87 ;;^UTILITY(U,$J,358.3,12888,1,4,0)
- +88 ;;=4^H35.013
- +89 ;;^UTILITY(U,$J,358.3,12888,2)
- +90 ;;=^5005584
- +91 ;;^UTILITY(U,$J,358.3,12889,0)
- +92 ;;=H35.011^^51^623^38
- +93 ;;^UTILITY(U,$J,358.3,12889,1,0)
- +94 ;;=^358.31IA^4^2
- +95 ;;^UTILITY(U,$J,358.3,12889,1,3,0)
- +96 ;;=3^Changes in Retinal Vascular Appearance,OD
- +97 ;;^UTILITY(U,$J,358.3,12889,1,4,0)
- +98 ;;=4^H35.011
- +99 ;;^UTILITY(U,$J,358.3,12889,2)
- +100 ;;=^5005582
- +101 ;;^UTILITY(U,$J,358.3,12890,0)
- +102 ;;=H35.012^^51^623^39
- +103 ;;^UTILITY(U,$J,358.3,12890,1,0)
- +104 ;;=^358.31IA^4^2
- +105 ;;^UTILITY(U,$J,358.3,12890,1,3,0)
- +106 ;;=3^Changes in Retinal Vascular Appearance,OS
- +107 ;;^UTILITY(U,$J,358.3,12890,1,4,0)
- +108 ;;=4^H35.012
- +109 ;;^UTILITY(U,$J,358.3,12890,2)
- +110 ;;=^5005583
- +111 ;;^UTILITY(U,$J,358.3,12891,0)
- +112 ;;=H35.023^^51^623^43
- +113 ;;^UTILITY(U,$J,358.3,12891,1,0)
- +114 ;;=^358.31IA^4^2
- +115 ;;^UTILITY(U,$J,358.3,12891,1,3,0)
- +116 ;;=3^Exudative Retinopathy,OU
- +117 ;;^UTILITY(U,$J,358.3,12891,1,4,0)
- +118 ;;=4^H35.023
- +119 ;;^UTILITY(U,$J,358.3,12891,2)
- +120 ;;=^5005588
- +121 ;;^UTILITY(U,$J,358.3,12892,0)
- +122 ;;=H35.021^^51^623^41
- +123 ;;^UTILITY(U,$J,358.3,12892,1,0)
- +124 ;;=^358.31IA^4^2